0 0.5 1 1.5+ All studies 62% 99 137,255 Improvement, Studies, Patients Relative Risk Primary outcome 52% 99 137,686 Mortality 49% 51 122,827 Ventilation 29% 18 33,157 ICU admission 38% 13 24,089 Hospitalization 34% 29 44,784 Recovery 43% 35 7,837 Cases 81% 16 13,696 Viral clearance 42% 30 4,157 RCTs 55% 46 11,855 Peer-reviewed 61% 83 125,940 Prophylaxis 85% 17 19,764 Early 62% 37 57,715 Late 41% 45 59,776 Ivermectin for COVID-19 c19ivm.org October 2023 after exclusions Favorsivermectin Favorscontrol